Antibody Pair for Amphiregulin (AREG)
AR; CRDGF; SDGF; Colorectum Cell-Derived Growth Factor; Schwannoma-Derived Growth Factor
- UOM
- FOB US$ 907.00 US$ 1,512.00 US$ 2,722.00 US$ 5,292.00 US$ 9,072.00
- Quantity
Overview
Properties
- Product No.PSA006Hu01
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- ApplicationsELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
Research use only - DownloadInstruction Manual
- CategoryCytokineTumor immunity
-
Reagent Contents
Recombinant Amphiregulin (AREG) 50ug Standard Monoclonal Antibody to Amphiregulin (AREG) 500ug Capture Ab Biotin-Linked Monoclonal Antibody to Amphiregulin (AREG) 50ug Detection Ab
Sign into your account
Share a new citation as an author
Upload your experimental result
Review

Contact us
Please fill in the blank.
Matching tests
Usage
The concentration of protein/peptide and antibodies used in different immunoassays need to be determined by users according to their experiments.
Storage
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
Stability
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Giveaways
Increment services
Citations
- Amphiregulin and Epiregulin Expression in Colorectal Carcinoma and the Correlation with Clinicopathological CharacteristicsKarger: 315380
- Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer.Pubmed:24800946
- Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancerPubMed: 25707609
- Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancerPubMed: 26195282
- Serum level of hepatocyte growth factor is a novel marker of predicting theoutcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancerPubmed:26716644
- Anti-asthmatic activity of alkaloid compounds from Pericarpium Citri Reticulatae (Citrus reticulata 'Chachi')Pubmed: 19363516
- CD9 regulates keratinocyte migration by negatively modulating the sheddase activity of ADAM17
- Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicinePubmed: 33212364
- Polarization of ADAM17‐driven EGFR signalling in electric field‐guided collective migration of epidermal sheetsPubmed: 33164313